References
- Canovas F, Dagneaux L. Quality of life after total knee arthroplasty. Orthop Traumatol Surg Res. 2018;104:41–46.
- McLawhorn AS, Buller LT. Bundled payments in total joint replacement: keeping our care affordable and high in quality. Curr Rev Musculoskelet Med. 2017;10:370–377.
- Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–785.
- Patel A, Pavlou G, Mújica-Mota RE, et al. The epidemiology of revision total knee and hip arthroplasty in England and Wales: a comparative analysis with projections for the United States. A study using the National Joint Registry dataset. Bone Joint J. 2015;97-B:1076–1081.
- Lamagni T. Epidemiology and burden of prosthetic joint infections. J Antimicrob Chemother. 2014;69:5–10.
- Whitehouse JD, Friedman ND, Kirkland KB, et al. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002;23:183–189.
- Kurtz SM, Lau E, Watson H, et al. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 2012;27:61–65.
- Coello R, Charlett A, Wilson J, et al. Adverse impact of surgical site infections in English hospitals. J Hosp Infect. 2005;60:93–103.
- Kapadia BH, McElroy MJ, Issa K, et al. The economic impact of periprosthetic infections following total knee arthroplasty at a specialized tertiary-care center. J Arthroplasty. 2014;29:929–932.
- Bozic K, Ong K, Lau E, et al. Estimating risk in medicare patients with THA: an electronic risk calculator for periprosthetic joint infection and mortality. Clin Orthop Relat Res. 2013;471:574–583.
- Lavernia C, Lee DJ, Hernandez VH. The increasing financial burden of knee revision surgery in the United States. Clin Orthop Relat Res. 2006;446:221–226.
- Kasch R, Assmann G, Merk S, et al. Economic analysis of two-stage septic revision after total hip arthroplasty: what are the relevant costs for the hospital's orthopedic department? BMC Musculoskelet Disord. 2016;17:112.
- Horan T, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–332.
- Jenks PJ, Laurent M, McQuarry S, et al. Clinical and economic burden of surgical site infection (SSI) and predicted financial consequences of elimination of SSI from an English hospital. J Hosp Infect. 2014;86:24–33.
- Kasch R, Merk S, Assmann G, et al. Comparative analysis of direct hospital care costs between aseptic and two-stage septic knee revision. Plos One. 2017;12:e0169558.
- Vanhegan IS, Malik AK, Jayakumar P, et al. A financial analysis of revision hip arthroplasty: the economic burden in relation to the national tariff. J Bone Joint Surg Br. 2012;94:619–623.
- Garrido-Gómez J, Arrabal-Polo MA, Girón-Prieto MS, et al. Descriptive analysis of the economic costs of periprosthetic joint infection of the knee for the public health system of Andalusia. J Arthroplasty. 2013;28:1057.
- Kallala RF, Vanhegan IS, Ibrahim MS, et al. Financial analysis of revision knee surgery based on NHS tariffs and hospital costs: does it pay to provide a revision service? Bone Joint J. 2015;97-B:197–201.
- Oduwole KO, Molony DC, Walls RJ, et al. Increasing financial burden of revision total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2010;18:945–948.
- Klouche S, Sariali E, Mamoudy P. Total hip arthroplasty revision due to infection: a cost analysis approach. Orthop Traumatol Surg Res. 2010;96:124–132.
- Assmann G, Kasch R, Maher CG, et al. Comparison of health care costs between aseptic and two stage septic hip revision. J Arthroplasty. 2014;29:1925–1931.
- Assmann G, Kasch R, Hofer A, et al. An economic analysis of aseptic revision hip arthroplasty: calculation of partial hospital costs in relation to reimbursement. Arch Orthop Trauma Surg. 2014;134:413–420.
- de Vries L, van der Weegen W, Neve W, et al. The effectiveness of debridement, antibiotics and irrigation for periprosthetic joint infections after primary hip and knee arthroplasty. A 15 years retrospective study in two community hospitals in the Netherlands. J Bone Joint Infect. 2016;1:20–24.
- Kuiper JWP, Vos SJC, Saouti R, et al. Prosthetic joint-associated infections treated with DAIR (debridement, antibiotics, irrigation, and retention): analysis of risk factors and local antibiotic carriers in 91 patients. Acta Ortop. 2013;84:380–386.
- Puhto A, Puhto T, Syrjala H. Short-course antibiotics for prosthetic joint infections treated with prosthesis retention. Clin Microbiol Infect. 2012;18:1143–1148.
- Grammatopoulos G, Bolduc M, Atkins BL, et al. Functional outcome of debridement, antibiotics and implant retention in periprosthetic joint infection involving the hip: a case-control study. Bone Joint J. 2017;99-B:614–622.
- Healy WL, Iorio R. Implant selection and cost for total joint arthroplasty: conflict between surgeons and hospitals. Clin Orthop Relat Res. 2007;457:57–63.
- Anderson DJ, Kirkland KB, Kaye KS, et al. Under-resourced hospital infection control and prevention programs: penny wise, pound foolish? Infect Control Hosp Epidemiol. 2007;28:767–773.